Other languages NextCell Pharma AB

Equities

NXTCL

SE0009723125

Delayed Nasdaq Stockholm Other stock markets 03:13:55 2024-06-27 EDT			5-day change	1st Jan Change
1.4 ^SEK	0.00%		-4.11%	-46.77%

06-12	Nextcell Pharma AB Receives Positive Recommendation from Data Safety Monitoring Board for Protrans-Young Study	CI
05-28	NextCell Pharma AB Announces Single Treatment with ProTrans Demonstrates Long-Term Therapeutic Effect over 5 Years	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Nextcell Pharma AB Receives Positive Recommendation from Data Safety Monitoring Board for Protrans-Young Study	06-12
NextCell Pharma AB Announces Single Treatment with ProTrans Demonstrates Long-Term Therapeutic Effect over 5 Years	05-28
Nextcell Pharma AB Elects Hans-Peter Ekre as New Chairman of the Board	05-27
NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024	04-25
NextCell Pharma AB Announces Swedish Health and Social Care Inspectorate Grants Their Cellaviva Tissue Establishment Permission to Handle Amniotic Tissue	04-22
Anders Essen-Möller Resigns as Chairman of NextCell Pharma AB	04-19
The Swedish Medical Products Agency Approves Subgroup Analysis in NextCell Pharma AB's ProTrans-Young study	03-27
NextCell Pharma AB Establishes QVance to Meet the Nordic's Need for Quality Analytics	03-14
NextCell Pharma AB Reports Earnings Results for the First Quarter Ended November 30, 2023	01-25
Nextcell Pharma Announces Updates Regarding Nextcell's Clinical Trials with Protrans	01-24
NextCell Pharma AB Announces Repeated Treatment with ProTrans Is Immunologically Safe	11-06
NextCell Pharma AB Reports Earnings Results for the Full Year Ended August 31, 2023	23-10-26
NextCell Pharma AB Reports Earnings Results for the Fourth Quarter Ended August 31, 2023	23-10-26
Nextcell Pharma, Lino Signs Distribution Deal in Sweden	23-10-10
Nextcell Pharma AB Signs an Agreement for A New Tissue Product with Linio	23-10-10
NextCell Pharma AB Reports Earnings Results for the Third Quarter and Nine Months Ended May 31, 2023	23-07-27
NextCell Pharma Moves to Last Stage of Pneumonia Therapy Study	23-07-05
NextCell Pharma AB Announces Treatment Start of Severe Pneumonia with High Dose of ProTrans	23-07-05
NextCell Pharma AB Reports Earnings Results for the Second Quarter and Six Months Ended February 28, 2023	23-04-27
FDA Approves a Product of Multiplied Stem Cells from Umbilical Cord Blood of NextCell Pharma AB	23-04-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages NextCell Pharma AB

Equities

NXTCL

SE0009723125

Other languages

Filters